Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3176-3186
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3176
Table 3 Clinical features and univariate prognosis of 49 patients with follicular lymphoma
Factors

3-year OS, % (SE)
5-year OS, % (SE)
Log-rank (P value)
Sex
M (30) 86.7 (0.05)63.3 (0.09)0.185
F (19)78.9 (0.09)63.1 (0.13)
Age (yr)
≤ 60 (32) 84.3 (0.05)71.9 (0.08)0.584
> 60 (17)82.4 (0.08)70.6 (0.13)
The presence or absence of B symptoms
Y (31)77.4 (0.08)58.1 (0.13)0.237
N (18)88.9 (0.06)72.2 (0.09)
Stage
I-II (17)94.1 (0.05)94.1 (0.05)0.043
III-IV (32)78.1 (0.06)65.6 (0.10)
Pathological grading
I (3)100.0100.00.321
II (16)87.5 (0.07)68.7 (0.12)
III (30)80.0 (0.05)73.3 (0.11)
BM infiltration
Y (10)70.0 (0.13)30.0 (0.15)0.007
N (39)89.7 (0.04)79.5 (0.08)
Involved lymph node area
≤ 4 (36)86.1 (0.05)72.2 (0.08)0.054
> 4 (13)76.9 (0.12)53.8 (0.19)
Hepatomegaly
Y (2)100.0100.00.835
N (47)85.1 (0.05)74.4 (0.08)
Splenomegaly
Y (10)80.0 (0.10)60.0 (0.14)0.169
N (39)84.6 (0.05)76.9 (0.09)
LDH
Normal (14)85.7 (0.10)71.4 (0.10)0.312
High (35)82.9 (0.05)68.6 (0.09)
Hb
< 120 g/L (20)75.0 (0.09)45.0 (0.12)0.011
≥ 120 g/L (29)89.7 (0.04)75.9 (0.09)
WBC
≤ 4 × 109/L (11)10072.7 (0.18)0.481
> 4 × 109/L (38)84.2 (0.05)65.8 (0.08)
WBC
≤ 10 × 109/L (42)88.1 (0.05)66.7 (0.08)0.813
> 10 × 109/L (7)71.4 (0.21)57.1 (0.21)
LYM
≤ 1 × 109/L (25)80.0 (0.09)68.0 (0.15)0.494
> 1 × 109/L (24)87.5 (0.05)66.7 (0.09)
PLT
≤ 80 × 109/L (9)10066.7 (0.19)0.998
> 80 × 109/L (40)82.5 (0.06)70.0 (0.08)
ALB
≤ 35 g/L (6)83.3 (0.15)66.7 (0.19)0.941
> 35 g/L (43)87.4 (0.05)67.2 (0.08)
GLB
≤ 34 g/L (44)87.9 (0.05)66.5 (0.08)0.758
> 34 g/L (5)80.0 (0.18)80.0 (0.18)
Ki-67
≤ 50% (27)96.2 (0.04)91.3 (0.06)0.004
> 50% (22)83.3 (0.15)31.2 (0.25)
Bcl-6+3283.9 (0.07)74.6 (0.09)0.926
Bcl-6-1710068.6 (0.19)
CD10+3585.7 (0.07)64.6 (0.11)0.293
CD10-1490.9 (0.09)90.9 (0.09)
Bcl-2+2591.4 (0.06)76.4 (0.09)0.493
Bcl-2-2480 (0.10)66.7 (0.15)